Ikarugamycin: a natural product inhibitor of clathrin ‐mediated endocytosis

Abstract
Ikarugamycin (IKA) is a previously discovered antibiotic, which has been shown to inhibit the uptake of oxidized low‐density lipoproteins in macrophages. Furthermore, several groups have previously used IKA to inhibit clathrin‐mediated endocytosis (CME) in plant cell lines. However, detailed characterization of IKA has yet to be done. Consequently, we performed biochemistry and microscopy experiments to further characterize the effects of IKA on CME. We show that IKA has an IC50 of 2.7 μM in H1299 cells and acutely inhibits CME, but not other endocytic pathways, in a panel of cell lines. Although long‐term incubation with IKA has cytotoxic effects, the short‐term inhibitory effects on CME are reversible. Thus, IKA can be a useful tool for probing routes of endocytic trafficking.

Source: Traffic - July 7, 2016 Category: Research Authors: Sarah R. Elkin, Nathaniel W. Oswald, Dana Kim Reed, Marcel Mettlen, John B. McMillan, Sandra L. Schmid Tags: Toolbox Source Type: research